Expansion opportunities Cresco Labs operates a large multi-state footprint with 79 dispensaries across eight states and ongoing store openings, including recent Ohio addition. This indicates ample cross-state sales potential, channel diversification, and opportunities to upsell distribution partnerships, equipment, packaging, and unified brand experiences across Sunnyside dispensaries.

Revenue optimization Q1 2026 revenue was $151.3 million, down slightly year over year as wholesale and retail sales softened. This signals a need for revenue enhancement strategies such as store-level promotional programs, loyalty integrations, and optimized merchandising and product mix to boost basket size and frequency across locations.

Strategic leadership Appointment of Andrea Berner as General Counsel underscores a focus on regulatory compliance and governance. This presents an opening to engage on compliance consulting, packaging labeling, and safety-certification services that align with Cresco’s growth and quality standards.

Dispenser ecosystem With Sunnyside dispensaries forming a nationwide retail network, there is potential to partner on in-store technology, point-of-sale upgrades, digital signage, e-commerce integration, and patient consumer education programs to drive traffic and conversion at the point of sale.

Sustainability and SEED Cresco emphasizes Social Equity and Educational Development through SEED initiatives. This offers opportunities to propose community-focused programs, supplier diversity projects, workforce development partnerships, and grant-based funding or sponsorships to strengthen local engagement and brand loyalty.